Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04596111 · ClinicalTrials.gov registry record

Physiological Variables and Rowing Performance.

A clinical trial, sponsored by Franklin Pierce University.

Completed
Registry status
12
Enrollment target

NCT04596111: Completed study, sponsored by Franklin Pierce University.

NCT04596111 is a clinical trial that has completed, run by Franklin Pierce University. The registered enrollment target is 12 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04596111 has completed, sponsored by Franklin Pierce University.

COMPLETED
Registry status
12 participants
Enrollment target

Study Summary

The purpose of this study is to investigate the association between the changes in physiological variables based on fitness testing and the changes in rowing performance.

Primary Outcome

Time to complete the 2,000-meter indoor rowing test

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2020-10-21
Est. Completion 2021-05-10
Franklin Pierce University

9 total trials

What the finished NCT04596111 record still lists

NCT04596111 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 12 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT04596111 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04596111 about?

NCT04596111 is a clinical study titled "Physiological Variables and Rowing Performance.". The purpose of this study is to investigate the association between the changes in physiological variables based on fitness testing and the changes in rowing performance.

What is the current status of trial NCT04596111?

This trial is currently completed. The enrollment target is 12 participants. The study started on 2020-10-21. Estimated completion is 2021-05-10.

Who is sponsoring clinical trial NCT04596111?

This trial is sponsored by Franklin Pierce University, which has 9 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02602769 · 12 participants

    Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome

  • NCT02605421 · 12 participants · Phase 2

    Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma

  • NCT02619448 · 12 participants · Early Phase 1

    Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC

  • NCT03311503 · 12 participants · Phase 1

    Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04596111, the US trial registry maintained by the National Library of Medicine. NCT04596111 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.